) in the 2nd quarter of 2017. Within the period of measuring of the said value, the Company has received the data relating to the fair value of assets and liabilities as a result, the value of the fixed
(%) 5.69% 9.51% 9.80% Return on Equity (%) 8.82% 15.44% 15.32% Efficiency Ratios Return on Assets (%) 6.27% 10.87% 10.68% Return on fixed assets (%) 46.78% 82.27% 89.99% Asset turnover times 1.10 1.14 1.09
result of the decline in desert café sales in Q1/2020 corresponding COVID-19 situation while fixed selling and administrative expenses in Q1/2020 remained constant (The result of cost-saving initiatives
May 2019. The Company still has fixed cost for the period of shutdown while doesn’t have sale revenue including cost per ton still high for production period which resulted from depreciation and the
principally engaged in distribution of product and equipment, design, assembly and installation, and maintenance service of pure water treatment system; including operate clinical business which Hemodialysis
engaged in distribution of product and equipment, design, assembly and installation, and maintenance service of pure water treatment system; including operate clinical business which Hemodialysis services
categories, boosting manufacturing production. Private investment indicators also signified growth, particularly in machinery and equipment. Nevertheless, public spending declined mainly from the contraction
%, respectively. The higher ratio on a period-on-period basis was attributable to the Company has some fixed costs that unchanged irrespective of the revenue in the first quarter of 2017. Selling expenses The
cash and cash equivalent, temporary investments, Social Security Office receivables and property, plant and equipment. As of 31 December 2016 and 30 June 2017, cash and cash equivalent together with
fixed asset investments such as 1.5 Tesla Magnetic Resonance Imaging Scanners and CT Scan 192 Slices in amounts of Baht 40.50 million and 19.18 million, respectively. Selling Expenses The selling expenses